Gracey R. Alexander

Treatment of a chemoresistant neuroblastoma cell line with the antimalarial ozonide OZ513

S. Joshi, D. Coulter, J. Sharp, 2016, BMC Cancer.

A novel dual epigenetic approach targeting BET proteins and HDACs in Group 3 (MYC-driven) Medulloblastoma

N. Mishra, S. Joshi, D. Coulter, 2022, Journal of Experimental & Clinical Cancer Research.

Synergistic efficacy of inhibiting MYCN and mTOR signaling against neuroblastoma

S. Joshi, D. Coulter, Nagendra K. Chaturvedi, 2021, BMC Cancer.

Effects of novel pyrrolomycin MP1 in MYCN amplified chemoresistant neuroblastoma cell lines alone and combined with temsirolimus

Yan Liu, Yan Liu, Zhen Qiao, 2019, BMC Cancer.

Effects of novel pyrrolomycin MP1 in MYCN amplified chemoresistant neuroblastoma cell lines alone and combined with temsirolimus

Yan Liu, Zhen Qiao, Rongshi Li, 2019, BMC Cancer.